Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design., Cheng, Huimin, Linhares Brian M., Yu Wenbo, Cardenas Mariano G., Ai Yong, Jiang Wenjuan, Winkler Alyssa, Cohen Sandra, Melnick Ari, MacKerell Alexander, et al. , J Med Chem, 2018 Sep 13, Volume 61, Issue 17, p.7573-7588, (2018)

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma., Cardenas, Mariano G., Yu Wenbo, Béguelin Wendy, Teater Matthew R., Geng Huimin, Goldstein Rebecca L., Oswald Erin, Hatzi Katerina, Yang Shao-Ning, Cohen Joanna, et al. , J Clin Invest, 2016 Sep 01, Volume 126, Issue 9, p.3351-62, (2016)

Targeting lymphomas through MALT1 inhibition., Fontan, Lorena, and Melnick Ari , Oncotarget, 2012 Dec, Volume 3, Issue 12, p.1493-4, (2012)

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma., Leshchenko, Violetta V., Kuo Pei-Yu, Shaknovich Rita, Yang David T., Gellen Tobias, Petrich Adam, Yu Yiting, Remache Yvonne, Weniger Marc A., Rafiq Sarwish, et al. , Blood, 2010 Aug 19, Volume 116, Issue 7, p.1025-34, (2010)

Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics., Zelent, Arthur, Petrie Kevin, Boix-Chornet Manuel, Melnick Ari M., Waxman Samuel, and Gore Steven D. , Cancer Res, 2008 Jul 01, Volume 68, Issue 13, p.4967-70, (2008)

Specific peptides for the therapeutic targeting of oncogenes., Prive, Gilbert G., and Melnick Ari , Curr Opin Genet Dev, 2006 Feb, Volume 16, Issue 1, p.71-7, (2006)